Science and Enterprise

Tag: equity

  • Biotech Secures $25 Million in Series B Financing

    AlloCure Inc., a privately-held biotechnology company in Burlington, Massachusetts, says it has closed a $25 million deal for series B venture financing. The series B round — the second financing installment after initial start-up — includes new syndicate member Lundbeckfond Ventures, as well as previous investors SV Life Sciences and Novo A/S. The company is…

  • Maryland University, VC Partner on Start-Up Accelerator

    Loyola University in Baltimore, Maryland  and Wasabi Ventures, a venture capital company in San Mateo, California, have begun a new-business accelerator near the university’s campus. As part of the collaboration, Wasabi’s co-founder Thomas “T.K.” Kuegler, a 1994 Loyola graduate, will serve as the university’s entrepreneur-in-residence. Loyola says the accelerator will provide opportunities for its students…

  • Private Equity Company Founds $50M Biologics Start-Up

    Celtic Therapeutics, a private equity company in the U.S. and Europe, has started a new company to bring to market therapies based on antibody drug conjugates (ADCs) that bind to and kill cells with the targeted properties. The new company, known as ADC Therapeutics and based in Lausanne, Switzerland will have an initial investment of…

  • GSK, Johnson & Johnson Join in Life Science Venture Fund

    The London-based venture capital company Index Ventures unveiled a new investment fund for early-stage life sciences companies, with pharmaceutical companies GlaxoSmithKline and Janssen, a division of Johnson & Johnson, among the investors. The Index Life VI fund, valued at €150 million ($US230 million), is the first for Index Ventures devoted solely to the life sciences.…

  • Osteoporosis Drug Developer Secures $28M in Series B Round

    Tarsa Therapeutics Inc., a Philadelphia-based developer of drugs to treat osteoporosis, has completed $28 million in new series B financing, the second round of funding after initial start-up. The financing package, announced on Friday, is led by a new investor in the company, Foresite Capital. The funding is expected to support the next commercialization and…

  • Irish Govt to Fund U.S. Life Sciences VC Presence in Ireland

    The government of Ireland plans to invest $37.5 million in Sofinnova Ventures, a venture capital firm in Menlo Park, California that supports start-ups in the health care field, for the company to establish a presence in Ireland. Ireland’s Minister for Jobs, Enterprise and Innovation, Richard Bruton (pictured right) made the announcement today during a visit…

  • Biotech Secures $13M in Series B Funding for Clinical Trial

    HemaQuest Pharmaceuticals Inc., a biotechnology company in San Diego, closed a $13 million extension of its series B financing, the second round of funding after initial start-up. The extension is funded by existing investors Aberdare Ventures, De Novo Ventures, Forward Ventures, Latterell Venture Partners, and Lilly Ventures. HemaQuest develops small molecule therapies to treat disorders…

  • Bellicum Pharma Lands $20M in Series B Finance Round

    Bellicum Pharmaceuticals Inc. in Houston, Texas says today it has raised $20 million in series B financing, the second round of investment after initial start-up. The company develops vaccines designed to attack specific disease-producing cells, including those causing life-threatening disorders such as cancer. The privately-held Bellicum says current and new investors contributed to this investment…

  • GE, Carbon Trust to Partner on Clean Tech Start-Up Support

    General Electric and the U.K. environmental organization Carbon Trust will collaborate on backing start-up companies in Europe focusing on clean technologies. The partnership comes as the share of European investment in clean energy has declined over the past five years. During the first 18 months of the partnership, the Carbon Trust and GE will identify…

  • Cancer Diagnostics Company Gains $5M in Early Round Funds

    On-Q-ity in Waltham, Massachusetts, a developer of cancer diagnostics technology, says it has added $5 million in series B financing, the second round of funding after initial start-up. Participants in the round are Mohr Davidow Ventures, Atlas Ventures, and Physic Ventures, all of which are current investors in the company. On-Q-Ty — short for Oncology…